Mandate

Vinge advises Lunar Bank on the sale of its Swedish consumer loan portfolio to Morrow Bank

August 20, 2024 Banking and Finance

Vinge has advised Lunar Bank A/S on the sale of its approximately SEK 1.6 billion consumer loan portfolio to Morrow Bank ASA.

The transaction comprises Lunar Bank’s entire Swedish consumer loan portfolio and will be completed as soon as the Danish FSA has approved the sale. While Lunar Bank continues to grow in the Swedish market through expansion of its offering of banking products and services, the transaction follows the strategic decision that broker lending is considered non-core for Lunar Bank and ensures that the loan portfolio is taken over by a lending specialist in Morrow Bank.

Vinge’s team consisted of Albert Wållgren, Lionardo Ojeda and Jolinn Uhlin.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026